<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7049240/results/search/country/results.xml">
  <result pre="to treat active PWID [9], while in many parts of" exact="the United States" post="of America active substance use remains an important barrier"/>
  <result pre="treat active PWID [9], while in many parts of the" exact="United States of America" post="active substance use remains an important barrier to treatment"/>
  <result pre="[9], while in many parts of the United States of" exact="America" post="active substance use remains an important barrier to treatment"/>
  <result pre="add crucial information to improve HCV service delivery and treatment." exact="Greece" post="has expressed its willingness to contribute to the WHO"/>
  <result pre="vulnerable population of PWID. The prevalence of HCV infection in" exact="Greece" post="is estimated to be between 0.83% and 1.79% [22],"/>
  <result pre="National and Kapodistrian University of Athens, Laiko General Hospital, Athens," exact="Greece" post="References 1NelsonPKMathersBMCowieBet al.Global epidemiology of hepatitis B and hepatitis"/>
  <result pre="the treatment cascade of chronic hepatitis B and C in" exact="Greece" post="using a telephone surveyJ Viral Hepat20152240941525209157 23GiannousisIPPapatheodoridisGVDeutschMJet al.The burden"/>
 </snippets>
</snippetsTree>
